Keith Wilson
Faculty Member
Last active: 11/2/2019

  1. The human intestinal microbiota of constipated-predominant irritable bowel syndrome patients exhibits anti-inflammatory properties. Gobert AP, Sagrestani G, Delmas E, Wilson KT, Verriere TG, Dapoigny M, Del'homme C, Bernalier-Donadille A (2016) Sci Rep : 39399
    › Primary publication · 27982124 (PubMed) · PMC5159846 (PubMed Central)
  2. The homing receptor CD44 is involved in the progression of precancerous gastric lesions in patients infected with Helicobacter pylori and in development of mucous metaplasia in mice. Garay J, Piazuelo MB, Majumdar S, Li L, Trillo-Tinoco J, Del Valle L, Schneider BG, Delgado AG, Wilson KT, Correa P, Zabaleta J (2016) Cancer Lett 371(1): 90-8
    › Primary publication · 26639196 (PubMed) · PMC4714604 (PubMed Central)
  3. Serum Fatty Acids Are Correlated with Inflammatory Cytokines in Ulcerative Colitis. Wiese DM, Horst SN, Brown CT, Allaman MM, Hodges ME, Slaughter JC, Druce JP, Beaulieu DB, Schwartz DA, Wilson KT, Coburn LA (2016) PLoS One 11(5): e0156387
    › Primary publication · 27227540 (PubMed) · PMC4882051 (PubMed Central)
  4. Pathogenic Helicobacter pylori strains translocate DNA and activate TLR9 via the cancer-associated cag type IV secretion system. Varga MG, Shaffer CL, Sierra JC, Suarez G, Piazuelo MB, Whitaker ME, Romero-Gallo J, Krishna US, Delgado A, Gomez MA, Good JA, Almqvist F, Skaar EP, Correa P, Wilson KT, Hadjifrangiskou M, Peek RM (2016) Oncogene 35(48): 6262-6269
    › Primary publication · 27157617 (PubMed) · PMC5102820 (PubMed Central)
  5. Myeloid translocation genes differentially regulate colorectal cancer programs. Parang B, Bradley AM, Mittal MK, Short SP, Thompson JJ, Barrett CW, Naik RD, Bilotta AJ, Washington MK, Revetta FL, Smith JJ, Chen X, Wilson KT, Hiebert SW, Williams CS (2016) Oncogene 35(49): 6341-6349
    › Primary publication · 27270437 (PubMed) · PMC5140770 (PubMed Central)
  6. L-Arginine Availability and Metabolism Is Altered in Ulcerative Colitis. Coburn LA, Horst SN, Allaman MM, Brown CT, Williams CS, Hodges ME, Druce JP, Beaulieu DB, Schwartz DA, Wilson KT (2016) Inflamm Bowel Dis 22(8): 1847-58
    › Primary publication · 27104830 (PubMed) · PMC4956554 (PubMed Central)
  7. Erratum to: Epigenetic and genetic variation in GATA5 is associated with gastric disease risk. Sobota RS, Kodaman N, Mera R, Piazuelo MB, Bravo LE, Pazos A, Zabaleta J, Delgado AG, El-Rifai W, Morgan DR, Wilson KT, Correa P, Williams SM, Schneider BG (2016) Hum Genet 135(8): 907-908
    › Primary publication · 27417435 (PubMed)
  8. Epigenetic silencing of miR-124 prevents spermine oxidase regulation: implications for Helicobacter pylori-induced gastric cancer. Murray-Stewart T, Sierra JC, Piazuelo MB, Mera RM, Chaturvedi R, Bravo LE, Correa P, Schneider BG, Wilson KT, Casero RA (2016) Oncogene 35(42): 5480-5488
    › Primary publication · 27041578 (PubMed) · PMC5050049 (PubMed Central)
  9. Epigenetic and genetic variation in GATA5 is associated with gastric disease risk. Sobota RS, Kodaman N, Mera R, Piazuelo MB, Bravo LE, Pazos A, Zabaleta J, Delgado AG, El-Rifai W, Morgan DR, Wilson KT, Correa P, Williams SM, Schneider BG (2016) Hum Genet 135(8): 895-906
    › Primary publication · 27225266 (PubMed) · PMC4947561 (PubMed Central)
  10. EGFR regulates macrophage activation and function in bacterial infection. Hardbower DM, Singh K, Asim M, Verriere TG, Olivares-Villagómez D, Barry DP, Allaman MM, Washington MK, Peek RM, Piazuelo MB, Wilson KT (2016) J Clin Invest 126(9): 3296-312
    › Primary publication · 27482886 (PubMed) · PMC5004944 (PubMed Central)